|
| 36253529 | Author Correction: Skeletal and extraskeletal disorders of biomineralization. | Nat Rev Endocrinol | 2023 |
| 37547321 | Anticipated effects of burosumab treatment on long-term clinical sequelae in XLH: expert perspectives. | Front Endocrinol (Lausanne) | 2023 |
| 36943390 | Murine models of HRAS-mediated cutaneous skeletal hypophosphatemia syndrome suggest bone as the FGF23 excess source. | J Clin Invest | 2023 |
| 37102469 | Coxa Vara Deformity in Fibrous Dysplasia/McCune-Albright Syndrome: Prevalence, Natural History and Risk Factors: A Two-Center Study. | J Bone Miner Res | 2023 |
| 37435833 | Infigratinib, a selective FGFR1-3 tyrosine kinase inhibitor, alters dentoalveolar development at high doses. | Dev Dyn | 2023 |
| 37091244 | An inducible explant model of osteoclast-osteoprogenitor coordination in exacerbated osteoclastogenesis. | iScience | 2023 |
| 36442958 | Emerging Role of <sup>18</sup>F-NaF PET/Computed Tomographic Imaging in Osteoporosis: A Potential Upgrade to the Osteoporosis Toolbox. | PET Clin | 2023 |
| 36812441 | Safety and Efficacy of Denosumab for Fibrous Dysplasia of Bone. | N Engl J Med | 2023 |
| 36739273 | Cell surface-bound La protein regulates the cell fusion stage of osteoclastogenesis. | Nat Commun | 2023 |
| 36593655 | Identification of GNAS Variants in Circulating Cell-Free DNA from Patients with Fibrous Dysplasia/McCune Albright Syndrome. | J Bone Miner Res | 2023 |
| 34809861 | Applications of Artificial Intelligence in <sup>18</sup>F-Sodium Fluoride Positron Emission Tomography/Computed Tomography:: Current State and Future Directions. | PET Clin | 2022 |
| 35578027 | Skeletal and extraskeletal disorders of biomineralization. | Nat Rev Endocrinol | 2022 |
| 36111273 | Precocious Puberty in a Boy With Bilateral Leydig Cell Tumors due to a Somatic Gain-of-Function <i>LHCGR</i> Variant. | J Endocr Soc | 2022 |
| 36066096 | Initial Assessment and Monitoring of Patients with Chronic Hypoparathyroidism: A Systematic Current Practice Survey. | J Bone Miner Res | 2022 |
| 35991529 | Infigratinib Reduces Fibroblast Growth Factor 23 (FGF23) and Increases Blood Phosphate in Tumor-Induced Osteomalacia. | JBMR Plus | 2022 |
| 35896375 | Tumour-induced osteomalacia: a rare cause of chronic pain and weakness. | Pract Neurol | 2022 |
| 36093861 | Determination of FGF23 Levels for the Diagnosis of FGF23-Mediated Hypophosphatemia. | J Bone Miner Res | 2022 |
| 36056624 | Fracture Risk in Pediatric Patients With MEN2B. | J Clin Endocrinol Metab | 2022 |
| 36161671 | Management of Hypoparathyroidism. | J Bone Miner Res | 2022 |
| 36054890 | Malignant Sarcomatous Degeneration of Craniofacial Fibrous Dysplasia. | J Craniofac Surg | 2022 |
| 35248187 | Calvarial hyperostosis in primary hyperparathyroidism and other settings of increased cAMP signalling. | Lancet | 2022 |
| 35238087 | Hypocitraturia Is an Untoward Side Effect of Synthetic Human Parathyroid Hormone (hPTH) 1-34 Therapy in Hypoparathyroidism That May Increase Renal Morbidity. | J Bone Miner Res | 2022 |
| 34585778 | PTH 1-34 Replacement Therapy Has Minimal Effect on Quality of Life in Patients With Hypoparathyroidism. | J Bone Miner Res | 2022 |
| 34464000 | PTH and FGF23 Exert Interdependent Effects on Renal Phosphate Handling: Evidence From Patients With Hypoparathyroidism and Hyperphosphatemic Familial Tumoral Calcinosis Treated With Synthetic Human PTH 1-34. | J Bone Miner Res | 2022 |
| 34809874 | Artificial Intelligence in Vascular-PET:: Translational and Clinical Applications. | PET Clin | 2022 |
| 34809862 | Artificial Intelligence in Medical Imaging and its Impact on the Rare Disease Community: Threats, Challenges and Opportunities. | PET Clin | 2022 |
| 32504138 | Tumor-Induced Osteomalacia. | Calcif Tissue Int | 2021 |
| 33512531 | Genotype-Phenotype Correlation in Fibrous Dysplasia/McCune-Albright Syndrome. | J Clin Endocrinol Metab | 2021 |
| 33839802 | Characterization of Oral Health Status in Chilean Patients with X-Linked Hypophosphatemia. | Calcif Tissue Int | 2021 |
| 33666701 | Clinical and molecular characterization of Chilean patients with X-linked hypophosphatemia. | Osteoporos Int | 2021 |
| 33772327 | Denosumab for craniofacial fibrous dysplasia: duration of efficacy and post-treatment effects. | Osteoporos Int | 2021 |
| 34788508 | Parathyroid Hormone Resistance and Autoantibodies to the PTH1 Receptor. | N Engl J Med | 2021 |
| 34692955 | Optic disc Edema in patients with fibrous dysplasia/McCune-Albright syndrome: Craniomorphometric analysis and peripapillary retinal nerve fiber layer data. | Data Brief | 2021 |
| 34425287 | Periorbital inflammation associated with craniofacial fibrous dysplasia: Report of three cases and review of the literature. | Bone | 2021 |
| 33977199 | A Cross-Sectional Cohort Study of the Effects of FGF23 Deficiency and Hyperphosphatemia on Dental Structures in Hyperphosphatemic Familial Tumoral Calcinosis. | JBMR Plus | 2021 |
| 33950530 | Burosumab for Tumor-Induced Osteomalacia: Not Enough of a Good Thing. | J Bone Miner Res | 2021 |
| 34167829 | Reply. | Ophthalmology | 2021 |
| 33314777 | Novel Majeed Syndrome-Causing LPIN2 Mutations Link Bone Inflammation to Inflammatory M2 Macrophages and Accelerated Osteoclastogenesis. | Arthritis Rheumatol | 2021 |
| 33049075 | C-Terminal, but Not Intact, FGF23 and EPO Are Strongly Correlatively Elevated in Patients With Gain-of-Function Mutations in HIF2A: Clinical Evidence for EPO Regulating FGF23. | J Bone Miner Res | 2021 |
| 32888946 | Ocular Adverse Effects of Infigratinib, a New Fibroblast Growth Factor Receptor Tyrosine Kinase Inhibitor. | Ophthalmology | 2021 |
| 32979536 | Optic disc edema in fibrous dysplasia/McCune-Albright syndrome: Prevalence, etiologies, and clinical implications. | Bone | 2021 |
| 32556405 | Successful Intravascular Treatment of an Intraosseous Arteriovenous Fistula in Fibrous Dysplasia. | Calcif Tissue Int | 2020 |
| 31673695 | Fibrous Dysplasia/McCune-Albright Syndrome: A Rare, Mosaic Disease of Gα⿿s Activation. | Endocr Rev | 2020 |
| 31924563 | Approach to patients with hypophosphataemia. | Lancet Diabetes Endocrinol | 2020 |
| 32631973 | Nephropathic Cystinosis: A Distinct Form of CKD-Mineral and Bone Disorder that Provides Novel Insights into the Regulation of FGF23. | J Am Soc Nephrol | 2020 |
| 32655879 | A rare cause of atraumatic fractures: case series of four patients with tumor-induced osteomalacia. | Clin Diabetes Endocrinol | 2020 |
| 32905668 | Targeted FGFR Blockade for the Treatment of Tumor-Induced Osteomalacia. | N Engl J Med | 2020 |
| 32644197 | Utility of Optical Coherence Tomography in the Diagnosis and Management of Optic Neuropathy in Patients with Fibrous Dysplasia. | J Bone Miner Res | 2020 |
| 32284396 | PET Imaging of Phosphodiesterase-4 Identifies Affected Dysplastic Bone in McCune-Albright Syndrome, a Genetic Mosaic Disorder. | J Nucl Med | 2020 |
| 32478399 | Denosumab for Fibrous Dysplasia: Promising, but Questions Remain. | J Clin Endocrinol Metab | 2020 |